COVID-19 Vaccine COVID-19 COVID-19 Vaccines mRNA Technology Export Markets RSV Vaccine Covid Vaccine Flu Vaccine Valneva Regulatory Approval Respiratory Vaccines Respiratory Diseases Respiratory Syncytial Virus Human Metapneumovirus Virus-like Particles Horseshoe Crab Blood Covid Vaccines Flu Clinical Trials Coronavirus Vaccines Oxford-AstraZeneca Covid Vaccine AstraZeneca Technology MMR Vaccine Production mRNA Vaccines Public Perception Manufacturing Bio-pharmaceutical Research Public Health Policy mRNA-based Vaccines Hepatitis B Development Diabetes Protein Applications Nanomaterials Protein Therapeutics HPV Vaccine Regulatory Affairs Moderna Covid-19 Vaccine
Executives blame weaker COVID demand alongside pending patent losses, signaling a near-term reset toward pipeline investment.